BioRender
PrivateLast Round
VC Round
Dec 16, 2025
Est. Valuation
$900M
Total Funding Raised
$45.12M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
BioRender is a software company that provides a science illustration software designed to empower the world to learn and communicate science through visuals.
Sector
Healthcare & Life Sciences
Verticals
Vertical SaaS, Content Creation, Data Visualization
Business Model
B2B
Customer Profile
Freemium, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BioRender Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
BioRender Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Dec 16, 2025 | ||||
| Series B | Mar 21, 2022 | ||||
| Accelerator | Mar 21, 2018 |
Key People
Founding team and executive leadership
BioRender Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Refactor Capital | Accelerator |
| TCV | Series B |
| Inovia Capital | Series B |
| Dimension | VC Round |
| Real Ventures | Series B |
| Y Combinator | Series B, Accelerator |
| Dimension | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 1, 2026
Reached over one million scientists using the platform.
- Mar 5, 2026
Appeared in over 54,000 scientific publications.
BioRender Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about BioRender's valuation, stock price, and market status.